Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Clostridium tetani toxin, also known as tetanus toxin or tetanospasmin, is a potent neurotoxin produced by the bacterium Clostridium tetani. It inhibits neurotransmitter release, specifically glycine and GABA, leading to unopposed muscle contraction and spasms. It functions as a zinc-dependent endopeptidase that cleaves synaptobrevin-2. Tetanus results from wound contamination with C. tetani spores; these spores germinate and produce toxins that disseminate via blood or lymphatics.
Zinc-dependent endopeptidase that cleaves synaptobrevin-2, blocking the release of inhibitory neurotransmitters glycine and GABA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Clostridium tetani Toxin (Tetanospasmin).